US · Healthcare

Biomind Labs Inc. (BMNDF)

Biotechnology

Biomind Labs Inc. (BMNDF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BMNDF

P/E ratio

18.00

Biomind Labs Inc. (BMNDF) — FAQ

What is BMNDF's P/E ratio?

The price-to-earnings (P/E) ratio for Biomind Labs Inc. (BMNDF) is 18.00 (data as of 2026-03-23).

Does Biomind Labs Inc. pay a dividend?

Dividend yield is not available in the current snapshot for Biomind Labs Inc. (BMNDF). Check the MyAverix Finance app for the latest dividend data.

What sector is Biomind Labs Inc. in?

Biomind Labs Inc. (BMNDF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is BMNDF listed on?

BMNDF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)